##plugins.themes.bootstrap3.article.main##

Haissam Yahya Nasser Alyami, Mohsen Saleh Muhammad Al Najrani, Fawzaih Salem Bakitan Alyami, Mohammed Faris Abdllah Almansour, Hussain Saleh Nasser Alyami, Hirfish Hamad Hadi Hirfish, Ghanem Mohammed Hussain Alrabie, Abdulaziz Ahmed Bin Marshad Alyami Yasser Mohummed Hamed Alsharif, Sultan Mohamed Rimthan Alsahli, Majed Hammad Bakhet Alsehli, Abdullah Fatm Hilal Almuttairi, Turki Hamed Thawab Alsehli, Naif Hamed Dughaylib Alsahli, Yousef Owaidh Alhurayr Alhrbi

Abstract

The COVID-19 pandemic has profoundly affected the pharmaceutical industry, reshaping priorities, accelerating innovation, and highlighting vulnerabilities in global healthcare systems. This article provides a comprehensive analysis of the impact of COVID-19 on the pharmaceutical sector, examining key lessons learned and offering insights into the future outlook. It explores the rapid development of vaccines and therapeutics, shifts in regulatory frameworks, supply chain disruptions, and changes in healthcare delivery models. Additionally, the article discusses the broader implications of the pandemic on drug discovery, clinical trials, digital health technologies, and collaboration within the industry. By synthesizing lessons from the pandemic response, this article aims to inform strategic planning and decision-making in the pharmaceutical industry as it navigates the post-pandemic landscape.

Metrics

File downloads
57

##plugins.themes.bootstrap3.article.details##

Section

How to Cite

The Impact Of Covid-19 On The Pharmaceutical Industry: Lessons Learned And Future Outlook. (2023). Journal of Namibian Studies : History Politics Culture, 36, 244-252. https://doi.org/10.59670/dbn91528